Cutting edge: permissive MHC class II allele changes the pattern of antitumor immune response resulting in failure of tumor rejection
about
A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancerProstate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine DesignHuman prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+.Prostate cancer and immunoproteome: awakening and reprogramming the guardian angels.Anti-tumor effect of the alphavirus-based virus-like particle vector expressing prostate-specific antigen in a HLA-DR transgenic mouse model of prostate cancer.The anti-tumor effect of Newcastle disease virus HN protein is influenced by differential subcellular targeting.Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy.Immunostimulatory early phenotype of tumor-associated macrophages does not predict tumor growth outcome in an HLA-DR mouse model of prostate cancer.Breaking immune tolerance by targeting CD25+ regulatory T cells is essential for the anti-tumor effect of the CTLA-4 blockade in an HLA-DR transgenic mouse model of prostate cancer.
P2860
Q36005476-142B607C-8700-4ABF-A0E9-DA5C0B6CE915Q36487242-62B7B164-B444-4AAD-932D-B91A55CB1732Q37435472-2364C5BD-4EA0-4F13-848D-9578115DCF7EQ38000961-C4FF6787-7978-4899-AD77-49506F9F1D5DQ38839675-EA4D0200-970A-46B7-B38B-A52E1E21F117Q39743977-B0E64EE6-2E99-41FA-B93F-9EFB63D725EDQ39776358-E84B56D4-8D51-423E-811C-E116F80FBA0FQ52950026-908AC45C-F077-4359-91C6-62E960F7FCF1Q53028366-E1DAE46D-C8BF-40AD-89AC-67B9678EF709
P2860
Cutting edge: permissive MHC class II allele changes the pattern of antitumor immune response resulting in failure of tumor rejection
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Cutting edge: permissive MHC c ...... in failure of tumor rejection
@en
Cutting edge: permissive MHC c ...... in failure of tumor rejection.
@nl
type
label
Cutting edge: permissive MHC c ...... in failure of tumor rejection
@en
Cutting edge: permissive MHC c ...... in failure of tumor rejection.
@nl
prefLabel
Cutting edge: permissive MHC c ...... in failure of tumor rejection
@en
Cutting edge: permissive MHC c ...... in failure of tumor rejection.
@nl
P2093
P2860
P1476
Cutting edge: permissive MHC c ...... in failure of tumor rejection
@en
P2093
Carla A Berard
Diana V Kouiavskaia
Elena N Klyushnenkova
Richard B Alexander
P2860
P304
P356
10.4049/JIMMUNOL.182.3.1242
P407
P577
2009-02-01T00:00:00Z